# Bone Healing During Ninlaro Exposure

> **NCT04028115** · PHASE2 · COMPLETED · sponsor: **Thomas Lund** · enrollment: 30 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Ixazomib

## Key facts

- **NCT ID:** NCT04028115
- **Lead sponsor:** Thomas Lund
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-24
- **Primary completion:** 2024-04-01
- **Final completion:** 2024-04-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2024-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04028115

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04028115, "Bone Healing During Ninlaro Exposure". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04028115. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*